The journal of sexual medicine · 2008
Clitoral atrophy: a case series.
Клинический случайСтатьяНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Amsterdam Alison, Krychman Michael
Аннотация
INTRODUCTION: Clitoral atrophy is often a neglected cause of female arousal complaints and warrants treatment with localized treatments.
AIM: This is a case series of patients with clitoral atrophy in which localized estrogens were used to treat separate, distinct sexual complaints.
METHODS: We report on three patients who were treated with localized estrogen tablets and cream for symptomatic clitoral atrophy despite a lack of data for use of these agents for the treatment of this diagnosis. The patients described here expressed understanding of the risks of vaginal hormonal therapy prior to treatment and at follow-up visits while on therapy.
MAIN OUTCOME MEASURES: Patient reports, physical examination, and vaginal pH.
RESULTS: All patients reported improvement or resolution of symptoms after the treatment with localized estrogen tablets and/or cream.
CONCLUSIONS: Low-dose minimally absorbed local estrogen products can be used in combination with excellent tolerance and low side-effect profile to treat female sexual complaints.
AIM: This is a case series of patients with clitoral atrophy in which localized estrogens were used to treat separate, distinct sexual complaints.
METHODS: We report on three patients who were treated with localized estrogen tablets and cream for symptomatic clitoral atrophy despite a lack of data for use of these agents for the treatment of this diagnosis. The patients described here expressed understanding of the risks of vaginal hormonal therapy prior to treatment and at follow-up visits while on therapy.
MAIN OUTCOME MEASURES: Patient reports, physical examination, and vaginal pH.
RESULTS: All patients reported improvement or resolution of symptoms after the treatment with localized estrogen tablets and/or cream.
CONCLUSIONS: Low-dose minimally absorbed local estrogen products can be used in combination with excellent tolerance and low side-effect profile to treat female sexual complaints.